Literature DB >> 6992609

Applicability of different antigen preparations in the enzyme-linked immunosorbent assay for schistosomiasis mansoni.

A M Deelder, D Kornelis, M Makbin, H N Noordpool, R M Codfried, J P Rotmans, B F Oostburg.   

Abstract

The applicability of seven different antigen preparations for the detection of antibodies against Schistosoma mansoni was tested in the enzyme-linked immunosorbent assay. For this purpose, sera from children and adults from Surinam infected with S. mansoni were screened for the presence of specific antibodies against the various antigens. With all antigens, generally better results were obtained with the sera from children than with those from adults. The best results were obtained when the trichloroacetic acid-soluble fraction of adult worm antigen (containing the proteoglycan circulating anodic antigen) was used.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6992609     DOI： 10.4269/ajtmh.1980.29.401

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  10 in total

1.  Immunoaffinity fractionation of Schistosoma mansoni worm antigens using human antibodies and its application for serodiagnosis.

Authors:  F N Boctor; H I Shaheen
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

2.  Recognition of schistosome glycolipids by immunoglobulin E: possible role in immunity.

Authors:  D van Der Kleij; A G Tielens; M Yazdanbakhsh
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  KCl-Extractable surface antigens of Schistosoma mansoni: immunological characterization and applicability in immunodiagnosis.

Authors:  J P Rotmans; G W Mooij
Journal:  Z Parasitenkd       Date:  1982

Review 4.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

5.  Macrophage activation as an immune correlate to protective immunity against schistosomiasis in mice immunized with an irradiated, cryopreserved live vaccine.

Authors:  F A Lewis; J Winestock; S L James
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

6.  A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics.

Authors:  Marie-Astrid Hoogerwerf; Jan Pieter R Koopman; Marijke C C Langenberg; Jacqueline J Janse; Janneke Kos-van Oosterhoud; Carola Feijt; Simon P Jochems; Claudia J de Dood; Roos van Schuijlenburg; Arifa Ozir-Fazalalikhan; Mikhael D Manurung; Erliyani Sartono; Martha T van der Beek; Béatrice M F Winkel; Petra H Verbeek-Menken; Koen A Stam; Fijs W B van Leeuwen; Pauline Meij; Angela van Diepen; Lisette van Lieshout; Govert J van Dam; Paul L A M Corstjens; Cornelis H Hokke; Maria Yazdanbakhsh; Leo G Visser; Meta Roestenberg
Journal:  Nat Med       Date:  2020-02-17       Impact factor: 53.440

Review 7.  Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels.

Authors:  Paul L A M Corstjens; Claudia J De Dood; Dieuwke Kornelis; Elisa M Tjon Kon Fat; R Alan Wilson; Thomas M Kariuki; Ruth K Nyakundi; Philip T Loverde; William R Abrams; Hans J Tanke; Lisette Van Lieshout; André M Deelder; Govert J Van Dam
Journal:  Parasitology       Date:  2014-06-16       Impact factor: 3.234

8.  Collaborative study on antigens for immunodiagnosis of schistosomiasis.

Authors:  K E Mott; H Dixon
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

9.  Detection of antibodies against circulating cathodic antigen of Schistosoma mansoni using the enzyme-linked immunosorbent assay.

Authors:  A M Deelder; W Van den Berge
Journal:  Z Parasitenkd       Date:  1981

10.  Antigen-based diagnosis of Schistosoma infection in travellers: a prospective study.

Authors:  Miriam Casacuberta-Partal; Jacqueline J Janse; Roos van Schuijlenburg; Jutte J C de Vries; Marianne A A Erkens; Kitty Suijk; Mariëlle van Aalst; Jaap J Maas; Martin P Grobusch; Perry J J van Genderen; Claudia de Dood; Paul L A M Corstjens; Govert J van Dam; Lisette van Lieshout; Meta Roestenberg
Journal:  J Travel Med       Date:  2020-07-14       Impact factor: 8.490
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.